Cerebrospinal fluid levels of 3‐methoxy4hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L‐DOPA 1

No abstract is available for this paper.

• Publication year

  1971

• Venue

  Journal of Neurochemistry

• Publication date

  1971-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1471-4159.1971.TB03753.X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid.

  1971cited by this paper
• L-Dopa: Effect on Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of Mice

  1970cited by this paper
• Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of Guam.

  1970cited by this paper
• Modification of Parkinsonism--chronic treatment with L-dopa.

  1969cited by this paper
• The metabolism of orally administered l‐DOPA in Parkinsonism

  1969cited by this paper
• L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism.

  1969cited by this paper
• Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

  1968cited by this paper
• 3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid.

  1968cited by this paper
• In vivo studies of the metabolism of norepinephrine in the central nervous system.

  1968cited by this paper
• On the occurrence of homovanillic acid and 5-hydroxyindol-3-ylacetic acid in the ventricular C.S.F. of patients suffering from parkinsonism.

  1967cited by this paper
• Determination of urinary 3-methoxy-4-hydroxyphenyl-ethylene glycol by gas-liquid chromatography and electron capture detection.

  1967cited by this paper
• Metabolic pathways of dopamine and norepinephrine in rabbit brain in vitro.

  1967cited by this paper
• 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

  1967cited by this paper
• THE METABOLISM OF [C14]NORADRENALINE BY CAT BRAIN IN VIVO *

  1963cited by this paper
• 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists

  1957cited by this paper

• Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

  2014cites this paper
• Cerebrospinal fluid biomarkers for neurodegenerative disorders

  2013cites this paper
• Problems associated with fluid biomarkers for Parkinson's disease.

  2010cites this paper
• A current analysis of behavioral problems in patients with idiopathic Parkinson's disease

  1989cites this paper
• Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

  1989cites this paper
• Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.

  1984cites this paper
• Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism.

  1984cites this paper
• Neurochemical Analysis of Rat Cisternal Cerebrospinal Fluid

  1983cites this paper
• 5 – Methods for Determining MHPG in Plasma, CSF, and Urine

  1983cites this paper
• 4 – Effects of Pharmacological Agents on MHPG

  1983cites this paper
• Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine.

  1981cites this paper
• Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy.

  1980cites this paper
• Neurochemical Alterations in Parkinson's Disease

  1980cites this paper
• Clinical and biochemical heterogeneity of depressive disorders.

  1978cites this paper
• 3-Methoxy-4-hydroxyphenylethyleneglycol (mhpg) transport from the spinal cord during spinal subarachnoid perfusion.

  1976cites this paper
• METABOLISM OF BIOGENIC AMINES IN THE CENTRAL NERVOUS SYSTEM OF MAN

  1976cites this paper
• Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.

  1975cites this paper
• Catecholamines and Depression: A Further Specification of the Catecholamine Hypothesis of the Affective Disorders

  1975cites this paper
• Catecholamine metabolism in health and disease.

  1974cites this paper
• Computer reconstruction of tyramine breakdown in brain.

  1974cites this paper
• Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders.

  1973cites this paper
• Fluorometric determination of homovanillic acid in the presence of other acid metabolites of catecholamines 1

  1973cites this paper
• NOREPINEPHRINE METABOLISM IN THE CENTRAL NERVOUS SYSTEM OF MAN: STUDIES USING 3‐METHOXY‐4‐HYDROXYPHENYLETHYLENE GLYCOL LEVELS IN CEREBROSPINAL FLUID

  1973cites this paper
• 5 The Pharmacotherapy of Parkinsonism

  1973cites this paper
• Cholinergic mechanism--monoamines relation in certain brain structures.

  1972cites this paper